Applying propensity methods to the United States transplant registry for external real-world evidence control arms for 5-year survival in the BENEFIT study
Open Access
- 11 October 2023
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (2) , 250-259
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Health and Human Services ($11 196 634, $13 239 950)
- U.S. Food and Drug Administration
This publication has 14 references indexed in Scilit:
- De novo or early conversion to everolimus and long-term cancer outcomes in kidney transplant recipients: A trial-based linkage studyAmerican Journal of Transplantation, 2018
- Strengths and weaknesses of using SRTR data to shape the management of the HIV-infected kidney transplant recipientAmerican Journal of Transplantation, 2017
- Belatacept and Long-Term Outcomes in Kidney TransplantationNew England Journal of Medicine, 2016
- Big Data in Organ Transplantation: Registries and Administrative ClaimsAmerican Journal of Transplantation, 2014
- Propensity Score Methods for Confounding Control in Nonexperimental ResearchCirculation: Cardiovascular Quality and Outcomes, 2013
- Covariate Balancing Propensity ScoreJournal of the Royal Statistical Society Series B: Statistical Methodology, 2013
- Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant RecipientsAmerican Journal of Transplantation, 2011
- A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)American Journal of Transplantation, 2010
- A New Equation to Estimate Glomerular Filtration RateAnnals of Internal Medicine, 2009
- Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration RateAnnals of Internal Medicine, 2006